Welcome to the website of the European Menopause and Andropause
Society.
This site includes information on perimenopause, early menopause,
menopause symptoms and long-term health effects of estrogen loss,
and a wide variety of therapies to enhance health.
IMPORTANT NOTICE: 1. This information is not medical advice and is not intended to
substitute for the evaluation of your individual health condition by
your personal doctor.
2. EMAS has several
corporate members. The content of the website however is
independent of corporate sponsorship!
Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy Johannes Bitzer, Peter Kenemans, Alfred O. Mueck, for the ’FSDeducation Group
pages 209-218
Abstract
Estrogen receptor (ER) and ER-related receptor expression in normal and atrophic human vagina Aldo Cavallini, Edoardo Dinaro, Alessandra Giocolano, Anna Maria Caringella, Roberto Ferreri, Valeria Tutino, Giuseppe Loverro
pages 219-225 Abstract
Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis Konstantinos Z. Vlasiadis, John Damilakis, George A. Velegrakis, Chris A. Skouteris, Ivoni Fragouli, Anastasia Goumenou, John Matalliotakis, Eugenios E. Koumantakis
pages 226-233 Abstract
Prevalence of osteoporosis in middle anatolian population using calcaneal ultrasonography method Didem Arslantas, Selma Metintas, Alaettin Unsal, Burhanettin Isikli, Cemalettin Kalyoncu, Ali Arslantas
pages 234-241 Abstract
Obesity, estrone, and coronary artery disease in postmenopausal women T.C.B.F. Silva, E. Barrett-Connor, J.A.F. Ramires, A.P. Mansur
pages 242-248 Abstract
Effects of estradiol and norethisterone on lipids, insulin resistance and carotid flow Cesar E. Fernandes, Luciano M. Pompei, Rogério B. Machado, José Arnaldo S. Ferreira, Nilson R. Melo, Sergio Peixoto
pages 249-258 Abstract
Resistance training prevents liver fat accumulation in ovariectomized rats Patrick Corriveau, Amélie Paquette, Martin Brochu, Denis Prud’homme, Remi Rabasa-Lhoret, Jean-Marc Lavoie
pages 259-267 Abstract
Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps Evrim Erdemoglu, Mehmet Güney, Nermin Karahan, Tamer Mungan
pages 268-274 Abstract
Morphometric analysis of the urethra of castrated female rats treated with tamoxifen Alesse Ribeiro dos Santos, Pedro Vitor Lopes-Costa, Júlio César Dias de Castro, Igor Cardoso Campos, Rafael Soares Borges, Cleicilene Gomes Pires, Karina Oliveira Drumond, Airlane Pereira Alencar, Benedito Borges da Silva
pages 275-280 Abstract
The short-term effect of increased body weight in menopausal Chinese women taking tibolone Peng-Hui Wang, Ming-Shyen Yen, Kuan Chong Chao, Chi-Ming Liu, Wen-Ling Lee
pages 281-282 Abstract
Access to article abstracts is open to all Alert recipients. Access to full-text articles is limited to print subscribers who have activated their online access. Activate your online access to your subscriptions at: http://www.maturitas.org/user/subscriptions
Letter of Invitation EMAS 2009
The
British Menopause Society is delighted to have the
opportunity to invite you all to London for the 2009 EMAS
meeting which will be held between 16th and 20th May at the Excel Centre in London's docklands. The Excel
Centre is a state of the art conference centre on the Thames
opposite the ancient maritime area of Greenwich and provides
a fascinating venue with easy access to the centre of
London. The centre is fully self-contained with dozens of
restaurants, bars, cafes and hotel rooms of all levels.
Prices are comparable to other major European cities.
The scientific programme will be
stimulating with focus on new developments and current
opinion from foremost opinion leaders in Europe. We plan to
reflect the multi-disciplinary nature of our speciality
incorporating special sessions for trainees, nurses and
primary care physicians. We will also be looking to
collaborate with other European menopause societies and any
expressions of interest at this stage are welcome.
Late spring is an ideal time to visit
London with all its parks and many cultural attractions. We
will provide you with a stimulating and varied social
programme to complement the science and look forward to
seeing you in London in May 2009.
Tim
Hillard
Congress President
Chairman Elect British Menopause Society
EMAS response to EMEA proposals on the evaluation of new
medicinal products in the treatment of primary osteoporosis
European Medicines Evaluation Agency (EMEA) has
ignored important information in its decision to recommend
that the risk/benefit balance of hormone replacement therapy
(HRT) does not justify its use as first-line therapy for the
indication for prevention of osteoporosis in women.
